More specifically, evidence has shown that, in non-small cell lung cancer patients, notably increased serum indoleamine-2,3-dioxygenase (IDO) levels, which were potentially produced by high-fiber diets, induced primary resistance to ICI treatment [155]. This evidence concerns the gene IDO2 and non-small cell lung carcinoma.